Search research articles
Contact Us
Filters
Showing results (31-40 of 93) with videos related to
Page
of 10
Sort By:
Heart (British Cardiac Society)
|
January 6, 1999
Audit of prehospital thrombolysis by general practitioners in peripheral practices in Grampian
J Rawles, C Sinclair, K Jennings, et al.
BMJ (Clinical Research Ed.)
|
August 28, 1998
Call to needle times after acute myocardial infarction in urban and rural areas in northeast Scotland: prospective observational study
J Rawles, C Sinclair, K Jennings, et al.
BMJ (Clinical Research Ed.)
|
December 11, 1999
Population based cost utility study of interferon beta-1b in secondary progressive multiple sclerosis
R B Forbes, A Lees, N Waugh, et al.
Health Technology Assessment (Winchester, England)
|
September 5, 2007
The clinical effectiveness and cost-effectiveness of inhaled insulin in diabetes mellitus: a systematic review and economic evaluation
C Black, E Cummins, P Royle, et al.
The Cochrane Database of Systematic Reviews
|
August 15, 2003
Inhaled insulin in diabetes mellitus
P Royle, N Waugh, L McAuley, et al.
The Cochrane Database of Systematic Reviews
|
July 22, 2004
Inhaled insulin in diabetes mellitus
P Royle, N Waugh, L McAuley, et al.
The West Indian Medical Journal
|
July 2, 2009
Age-specific incidence of cancer in Kingston and St Andrew, Jamaica, 1998-2002
T N Gibson, G Blake, B Hanchard, et al.
Health Bulletin
|
September 1, 1991
A new Pick based computer thyroid register based on the national SAFUR requirements for local usage
R T Jung, A Scott, P Chong, et al.
Thorax
|
January 26, 2002
Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review
A Clegg, D A Scott, P Hewitson, et al.
Health Technology Assessment (Winchester, England)
|
June 18, 2002
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer
A Clegg, D A Scott, M Sidhu, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 93) with videos related to
Sort By:
Page
of 10
Heart (British Cardiac Society)
|
January 6, 1999
Audit of prehospital thrombolysis by general practitioners in peripheral practices in Grampian
J Rawles, C Sinclair, K Jennings, et al.
BMJ (Clinical Research Ed.)
|
August 28, 1998
Call to needle times after acute myocardial infarction in urban and rural areas in northeast Scotland: prospective observational study
J Rawles, C Sinclair, K Jennings, et al.
BMJ (Clinical Research Ed.)
|
December 11, 1999
Population based cost utility study of interferon beta-1b in secondary progressive multiple sclerosis
R B Forbes, A Lees, N Waugh, et al.
Health Technology Assessment (Winchester, England)
|
September 5, 2007
The clinical effectiveness and cost-effectiveness of inhaled insulin in diabetes mellitus: a systematic review and economic evaluation
C Black, E Cummins, P Royle, et al.
The Cochrane Database of Systematic Reviews
|
August 15, 2003
Inhaled insulin in diabetes mellitus
P Royle, N Waugh, L McAuley, et al.
The Cochrane Database of Systematic Reviews
|
July 22, 2004
Inhaled insulin in diabetes mellitus
P Royle, N Waugh, L McAuley, et al.
The West Indian Medical Journal
|
July 2, 2009
Age-specific incidence of cancer in Kingston and St Andrew, Jamaica, 1998-2002
T N Gibson, G Blake, B Hanchard, et al.
Health Bulletin
|
September 1, 1991
A new Pick based computer thyroid register based on the national SAFUR requirements for local usage
R T Jung, A Scott, P Chong, et al.
Thorax
|
January 26, 2002
Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review
A Clegg, D A Scott, P Hewitson, et al.
Health Technology Assessment (Winchester, England)
|
June 18, 2002
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer
A Clegg, D A Scott, M Sidhu, et al.
Page
of 10